Virtus LifeSci Biotech Products ETF (NYSEARCA:BBP) Short Interest Down 44.7% in June

Virtus LifeSci Biotech Products ETF (NYSEARCA:BBP) saw a significant decline in short interest during the month of June. As of June 15th, there was short interest totaling 7,733 shares, a decline of 44.7% from the May 31st total of 13,976 shares. Based on an average daily volume of 5,224 shares, the days-to-cover ratio is currently 1.5 days. Approximately 1.1% of the company’s shares are short sold.

Institutional Investors Weigh In On Virtus LifeSci Biotech Products ETF

Institutional investors and hedge funds have recently made changes to their positions in the stock. Flow Traders U.S. LLC bought a new position in shares of Virtus LifeSci Biotech Products ETF during the second quarter worth about $431,000. Comprehensive Financial Planning Inc. PA acquired a new position in shares of Virtus LifeSci Biotech Products ETF in the fourth quarter worth approximately $557,000. Finally, Prime Capital Investment Advisors LLC acquired a new position in shares of Virtus LifeSci Biotech Products ETF in the fourth quarter worth approximately $1,896,000.

Virtus LifeSci Biotech Products ETF Stock Performance

NYSEARCA BBP traded down $0.25 on Wednesday, reaching $96.02. The company had a trading volume of 9,937 shares, compared to its average volume of 7,818. Virtus LifeSci Biotech Products ETF has a fifty-two week low of $58.52 and a fifty-two week high of $97.49. The business has a 50 day moving average of $87.69 and a two-hundred day moving average of $84.19.

About Virtus LifeSci Biotech Products ETF

The Virtus LifeSci Biotech Products ETF (BBP) is an exchange-traded fund that is based on the LifeSci Biotechnology Products index. The fund tracks an index of US-listed biotechnology companies considered to be in the product stage by the index provider. BBP was launched on Dec 17, 2014 and is managed by Virtus.